Register entry
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
- Registered sites
- 1
- Drug products
- 1
- Live patents
- 69
- Countries
- 1
- Base
- Ireland
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureFinished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED | BLANCHARDSTOWNIreland | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3013428851 |
Exclusivity
Patents
69Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| ACTHAR GEL | CORTICOTROPIN | Jul 2041 |
| ACTHAR GEL (AUTOINJECTOR) | CORTICOTROPIN | Jul 2041 |
| INOMAX | NITRIC OXIDE | Jun 2029 |
| INOMAX | NITRIC OXIDE | Dec 2029 |
| INOMAX | NITRIC OXIDE | Jan 2031 |
| INOMAX | NITRIC OXIDE | Jul 2031 |
| INOMAX | NITRIC OXIDE | Feb 2035 |
| INOMAX | NITRIC OXIDE | Aug 2035 |
| INOMAX | NITRIC OXIDE | May 2036 |
| INOMAX | NITRIC OXIDE | Nov 2036 |
| TERLIVAZ | TERLIPRESSIN ACETATE | Apr 2037 |
| XARTEMIS XR | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | Jun 2027 |
| XARTEMIS XR | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | Mar 2029 |
| XARTEMIS XR | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | Nov 2029 |
| XARTEMIS XR | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | Dec 2030 |
| XARTEMIS XR | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | May 2032 |
Catalogue
Marketed products
1Showing 1 of 1.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Corticotropin | SOLUTION | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.